POCUS for Small Bowel Obstruction in the ED: a Retrospective Study (SBOCUS)

May 9, 2023 updated by: Carmine Cristiano Di Gioia, Azienda Ospedaliero-Universitaria di Modena

The Impact of Point-of-care Ultrasound on the Diagnosis and Management of Small Bowel Obstruction in the Emergency Department: a Retrospective Observational Single-center Study

This study protocol aims to evaluate the impact of point-of-care ultrasound (POCUS) on the diagnosis and management of small bowel obstruction (SBO) in the emergency department (ED). SBO is a potentially life-threatening condition that requires prompt diagnosis and management. Currently, the diagnosis of SBO is based on clinical evaluation and imaging tests, including plain abdominal radiography and computed tomography (CT) scan. POCUS is a bedside imaging technique that is rapid, non-invasive, repeatable, cost-effective and radiation-free, and can provide valuable information for the diagnosis and management of SBO. The primary objective of this study is to compare the time to diagnosis of SBO between patients who undergo POCUS intestinal loops examination and those who do not undergo POCUS in the ED. The secondary objectives include comparing the hospital length of stay, the rate of surgical intervention, the rate of complications, and the mortality rate between the two groups. This is a monocentric retrospective cohort study that will include all adult patients (> 18 years old) who presented to the ED with suspected SBO. The study population will be divided into two groups: the POCUS group and the non-POCUS group. The sample size calculation will be based on the assumption of a 30% reduction in the time to diagnosis of SBO in the POCUS group compared to the non-POCUS group, with a power of 80%. The results of this study may provide more robust evidence on the diagnostic accuracy and impact of POCUS for SBO in the ED.

Study Overview

Status

Not yet recruiting

Study Type

Observational

Enrollment (Anticipated)

230

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The study population will be divided into two groups:

  1. The POCUS group: patients who were evaluated by ED physicians who perform POCUS intestinal loops examination as part of their clinical practice
  2. The non-POCUS group: patients who were evaluated by ED physicians who do not perform POCUS intestinal loops examination for any reason.

Description

Inclusion Criteria:

  • Age > 18 years old
  • Clinical suspicion of SBO based on history and physical examination
  • Plain abdominal radiography (AXR) or CT scan performed in the ED

Exclusion Criteria:

  • Pregnancy
  • Known bowel obstruction
  • Previous abdominal surgery within 30 days
  • Refusal or inability to consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
The POCUS group
Patients who were evaluated by ED physicians who perform POCUS intestinal loops examination as part of their clinical practice
The non-POCUS group
Patients who were evaluated by ED physicians who do not perform POCUS intestinal loops examination for any reason

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to diagnosis of SBO by POCUS or CT scan
Time Frame: All patients will be seen by the emergency physician within 6 hours of admission to the emergency department.
The primary outcome will be the time to diagnosis of SBO by POCUS or CT scan, defined as the interval between the ED arrival and the confirmation of SBO by either imaging modality, comparing the two groups.
All patients will be seen by the emergency physician within 6 hours of admission to the emergency department.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The hospital length of stay
Time Frame: Patients will be followed up for a maximum of 2 months from admission to the emergency department, until discharge or death.
The interval between the ED arrival and the hospital discharge
Patients will be followed up for a maximum of 2 months from admission to the emergency department, until discharge or death.
The rate of surgical intervention
Time Frame: Patients will be followed up for a maximum of 2 months from admission to the emergency department, until discharge or death.
The proportion of patients who underwent laparotomy or laparoscopy for SBO
Patients will be followed up for a maximum of 2 months from admission to the emergency department, until discharge or death.
The rate of complications
Time Frame: Patients will be followed up for a maximum of 2 months from admission to the emergency department, until discharge or death.
The proportion of patients who developed bowel ischemia, perforation, peritonitis or sepsis during their hospitalization
Patients will be followed up for a maximum of 2 months from admission to the emergency department, until discharge or death.
The mortality rate
Time Frame: Patients will be followed up for a maximum of 2 months from admission to the emergency department, until discharge or death.
The proportion of patients who died during their hospitalization or within 30 days after their ED arrival
Patients will be followed up for a maximum of 2 months from admission to the emergency department, until discharge or death.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

September 1, 2023

Primary Completion (Anticipated)

December 31, 2023

Study Completion (Anticipated)

February 1, 2024

Study Registration Dates

First Submitted

May 9, 2023

First Submitted That Met QC Criteria

May 9, 2023

First Posted (Actual)

May 18, 2023

Study Record Updates

Last Update Posted (Actual)

May 18, 2023

Last Update Submitted That Met QC Criteria

May 9, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • SBOCUS2023

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Small Bowel Obstruction

3
Subscribe